Yuji Kan & Hisashi Uhara. (2024). Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYuji Kan and Hisashi Uhara. Successful Treatment of Acrodermatitis Continua of Hallopeau by TYK2 Inhibitor with Every Other Day. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationYuji Kan and Hisashi Uhara. Successful Treatment of Acrodermatitis Continua of Hallopeau by TYK2 Inhibitor with Every Other Day. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.